| Protocol No. | Title | Status |
| 05-0226-04 | Arizona Lymphoid Tissue and Blood Repository (ALTBR) | Open |
| 09-0679-04 | A Phase II Study Of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) For Treatment Of Hematologic Malignancies And Hematopoietic Failure States | Open |
| 12-0148-04 | A multicenter safety study of unlicensed investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patients | Open |
| 12-0222-04 | SWOG1117, "A Randomized Phase II Study of Azacitidine in Combination with
Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in
Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic
Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)". | Open |
| 12-0934-10 | E2906 Phase III Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age ¡Ý60 Years) | Open |
| 13-0057-10 | SWOG 1203 A Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML) | Open |
| 20120158 | CC-5013-AML-001 A PHASE 2, MULTICENTER, RANDOMIZED, OPENLABEL, PARALLEL-GROUP STUDY OF A LENALIDOMIDE (REVLIMID®) REGIMEN OR A SEQUENTIAL AZACITIDINE (VIDAZA®) PLUS LENALIDOMIDE (REVLIMID®) REGIMEN VERSUS AN
AZACITIDINE (VIDAZA®) REGIMEN FOR THERAPY OF OLDER SUBJECTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
| Open |
| NMDP2011-0264 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications, version 3.0 | Open |